REFERENCES
- American Cancer Society. Cancer Facts and Figures—1995. Atlanta, GA, 95-375M-No5008.95; 1995.
- Silverberg E, Boring C, Squires TS. Cancer statistics 1990. CA. 1990; 40:9–26.
- Gordon GB, Helzlouer KJ, Comstock GW. Serum levels of dehydroepiandrosterone and its sulfate and the risk of developing bladder cancer. Cancer Res. 1991; 51:1366- 1369.
- Rubben H, Lutzeyer W, Wallace DMA, Zingg EJ, Wallace DM,The epidemiology and aetiology of bladder cancer eds. Bladder Cancer, Clinical Practice in Urology Series. New York: Springer; 1985:1–27.
- Sporn MB. Carcinogenesis and cancer: different perspectives on the same disease. Cancer Res. 1991; 51:6215–6218.
- Perera FP. Molecular cancer epidemiology: a new tool in cancer prevention. J Natl Cancer Inst. 1987;78:887–898.
- Singh J, Kelloff G, Reddy BS. Effect of chemopreventive agents on intermediate biomarkers during different stages of azoxymethane-induced colon carcinogenesis. Cancer Epidem. Biomarkers Prevention. 1992;1:405–411.
- Hsieh JT, Verma AK. Involvement of protein kinase C in the transcriptional regulation of ornithine decarboxylase gene expression by 12-o-tetradecanoylphorbol-13-acetate in T24 human bladder carcinoma cells. Arch Biochem Biophys. 1988;262:326–336.
- Russell DH. Ornithine decarboxylase: A key regulatory enzyme in normal and neoplastic growth. Drug Metabolic Rev. 1985;16:1–88.
- Anderson G, Heby O. Polyamine and nucleic acid concentrations in Ehrlich ascites carcinoma cells and liver of tumor bearing mice at various stages of tumor growth. J Natl Cancer Inst. 1972; 48:165–172.
- O'Brian TG. The induction of ornithine decarboxylase as an early possibly obligatory event in mouse skin carcinogenesis. Cancer Res. 1976;36:2644–2653.
- Luk GD, Hamilton SR, Yang P, et al. Kinetic changes in mucosal ornithine decarboxylase activity during azoxymethane-induced colonic carcinogenesis in the rat. Cancer Res. 1986;46:4449–4452.
- Kingsworth AN, King WWK, Diekema KA, McCann PP, Ross JS, Malt RA. Inhibition of ornithine decarboxylase with 2-difluoromethylornithine: reduced incidence of dimethylhydrazine induced colon tumor in mice. Cancer Res. 1983;43:2545–2549.
- Gilmour SK, Verma AK, Madara T, O'Brien TG. Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis. Cancer Res. 1987; 47:1221–1225.
- Claverie N, Mamont PS. Comparative antitumor properties in rodents of irreversible inhibitors of l- ornithine decarboxylase, used as such or as prodrugs. Cancer Res. 1989;49:4466–4471.
- Homma Y, Kakizoe T, Samma S, Oyasu R. Inhibition of n-butyl -n-(4-hydroxybutyl) nitrosamine- induced rat urinary bladder carcinogenesis by a-difluoromethylornithine. Cancer Res. 1987;47:6176–6179.
- Ross RK, Paganini-Hill A, Henderson BE. Epidemiology of bladder cancer. In: Skinner D, Lieskovsky G, eds. Diagnosis and Management of Genitourinary Cancer. Philadelphia, PA: Saunders; 1988:2331.
- Case RAM, Hosker ME, McDonald DB, Pearson JT. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry, 1: the role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine. Br J Ind Med. 1954; 11:75–104.
- Melick WF, Naryka JJ, Kelly RE. Bladder cancer due to exposure to para-aminobiphenyl: a 17-year followup. J Urol. 1971; 106:220–226.
- Haugen DA, Peak MJ, Suhbler KM, Stamoudis VC. Isolation of mutagenic amines from a coal conversion oil by cation exchange chromatography. Anal Chem. 1982;54:32–37.
- Talaska G, Al-Juburi AZSS, Kadlubar FF. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8- yl) 4-aminobipheny l as a major adduct. Proc Natl Acad Sci. 1991;88:5350–5354.
- Kuller LH, Garfinkel L, Correa P, et al. Contribution of passive smoking to respiratory cancer. Environ Health Perspect. 1986;70:57–69.
- Seidel ER. Hormonal regulation of postprandial induction of gastrointestinal ornithine decarboxylase activity. Am J Physiol. 1986;251:460–466.
- Bachrach U. The induction of ornithine decarboxylase in normal and neoplastic cells. In: Gaugus JM, ed. Polyamines in Biomedical Research. New York: Wiley; 1980:81–107.
- Nicolson GL. Gene expression, cellular diversification and tumor progression to the metastatic pheno- type. BioEssays. 1991;13:337–342.
- Bubenick J, Baresova M, Vicklicky V, Jakoubkova J, Sainerova H, Donner J. Established cell line of urinary bladder carcinoma (T24) containing tumour specific antigen. Int J Cancer. 1973; 11:765–773.
- Anderson NL. Two-Dimensional Electrophoresis: Operation of the ISO-DALT System. Washington, DC: Large Scale Biology; 1988.
- Pegg AE. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res. 1988;44:4924–4928.
- Nishioka K, Grossie VB, Chang TH, Ajani JA, Ota DM. Colorectal ornithine decarboxylase activity in human mucosa and tumors: elevation of enzymatic activity in distal mucosa. J Surg Oncol. 1991;47:117–120.
- Moorhead RJ, Hoper M, McKelvey STD. Assessment of ODC activity in rectal mucosa as a marker for colorectal adenomas and carcinomas. Br J Surg. 1987; 74:364–365.
- Love RR, Surawicz TS, Morrisey JF, Verma AK. Levels of colorectal ornithine decarboxylase activity in patients with colon cancer, a family history of nonpolypos is hereditary colonic cancer, a family history of nonpolypos is hereditary colonic cancer and adenomas. Cancer Epidemiol Biomarkers Prev. 1992; 1:195–198.
- Miller MJ, Schwartz DM, Thorgeirsson SS. Inter- and intraclonal variability of polypeptides synthesized in a rat hepatoma cell line: quantitative two-dimensional gel analysis. J Biol Chem. 1988; 263:1122711236.
- Hemstreet GP, Rao JY, Hurst RE, et al. Intermediate endpoint biomarkers for chemoprevention. J Cell Bio chem Suppl. 1992;161:93–110.